Viewing Study NCT02807961


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-29 @ 2:55 AM
Study NCT ID: NCT02807961
Status: TERMINATED
Last Update Posted: 2019-10-22
First Post: 2016-06-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers
Sponsor: Eloxx Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Genetic Diseases View
None Nonsense Mutations View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Translational read through View